Synthesis, DFT, Molecular Docking, and Antimicrobial Studies of New Indole-Thiosemicarbazone Ligand and Their Complexes with Fe(III), Co(II), Ni(II), Cu(II)

Umesh Kumar,Jugmendra Singh,Seema Gautam,Madhur B Singh,Prashant Singh
DOI: https://doi.org/10.1002/cbdv.202401301
2024-09-05
Abstract:Indole-3-carbaldehyde based novel ligand (E)-2-((1-benzyl-1H-indol-3-yl)methylene)-N-methylhydrazine-1-carbothioamide (MBIHC) and their complexes [(MBIHC)2FeCl2]Cl(C1), [(MBIHC-)2Co] (C2), [(MBIHC-)2Ni] (C3), and [(MBIHC-)2Cu] (C4) have been synthesized. All compounds have been characterized by spectroanalytical techniques. The structure of MBIHC was confirmed by single-crystal X-ray data. The geometry of complexes was determined by spectroscopic and computational studies. In the case of iron complex, ligand MBIHC coordinated to the metal ion in bidentate mode (N and S) while in the case of cobalt, nickel, and copper complexes ligand act as a tridentate ligand (N, S and C). In vitro,antifungal and antibacterial studies of ligand and metal complexes were assayed against C. albicans, C. glabrata, E. coli, and K. pneumoniae pathogens. In antifungal activity, complex C1 exhibited a greater inhibition zone than the other compounds for the both examined fungi C. albicans (24±0.32 mm) and C. glabrata (20±0.16 mm).. However, the antifungal activities of complex C2has shown better activity against both E. coli (25±0.24 mm) and K. pneumoniae (16±0.80 mm) pathogens than the other examined compound.. Complex C2 has found even better than the benchmark drug Ampiciline in case of E. coli. Further, the DFT calculations and molecular docking studies also validate the experimental bioactivity results of examined compounds.
What problem does this paper attempt to address?